Scott Elliott Bio

Scott Elliott, co-head of the Firm’s Life Sciences Practice, focuses his practice on corporate and transactional matters including mergers and acquisitions, corporate financing transactions and general corporate and securities law issues. He advises clients in various industries including life sciences and technology, and their investors. He has represented software, hardware, medical device and other technology companies in their incorporation to venture funding, growth counseling to sale or IPO. He has extensive experience advising public and private company clients and financial sponsors on acquisitions, buyouts, going-private transactions, and minority investments as well as public and private securities offerings. Prior to joining O’Melveny, Scott was a partner at another AmLaw 50 firm.